Article info
PDFHepatology
Original article
Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study
- Correspondence to Dr Enrico N De Toni, Department of Internal Medicine 2, University of Munich, Muenchen 80333, Germany; enrico.detoni{at}med.uni-muenchen.de
Citation
Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study
Publication history
- Received December 28, 2018
- Revised February 12, 2019
- Accepted February 21, 2019
- First published March 16, 2019.
Online issue publication
December 06, 2019
Article Versions
- Previous version (6 December 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.